Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 17;110(8):5312–5316. doi: 10.1097/JS9.0000000000001602

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

(A) Flowchart of study selection and analyses. (B) Network plot of seven treatments on tr-AEs. The width of lines is proportional to the number of trials, the circle is the sample size. (C) Multiple comparison for tr-SAE based on network consistency model (OR >1) indicates higher incidence rate of tr-SAE (Amiv-bela-chemo: amivantama plus belazertinibe plus chemotherapy. Amiv-chemo: amivantama plus chemotherapy. Catum-chemo: catumaxomab plus chemotherapy). Contorl including single agent pembrolizumab, ipilimumab, or chemotherapy. Forest Plot of incidence rate of tr-AEs, subgroup analysis according to (D) BsAbs’ type and (E) pathological type of cancer.